Sign inJoin waitlistJoin the waitlist

Robert McWilliams

Vice President and Deputy Director of the OSF HealthCare Cancer Institute · University of Illinois College of Medicine at Rockford

Credentials: · · · · ·

History

OSF HealthCare
2026–Present

Medical Oncology
2000–2002
Internal Medicine
1997–2000
George Washington Univ Sch of Med
1993–1997

Research

Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort,…
The Lancet Oncology · 2020 · 2,115 citations
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
Journal of Clinical Oncology · 2009 · Last of 10 authors · 1,031 citations
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
Nature Genetics · 2010 · 523 citations

Svetomir Markovic
33 papers
Lisa Kottschade
30 papers
Thor Halfdanarson
27 papers · 3 as a fellow
Amit Mahipal
25 papers
Mitesh Borad
23 papers
Matthew Block
22 papers · 2 as a fellow
Tanios Bekaii-Saab
21 papers
Wen Ma
19 papers
Mark Truty
17 papers
Rondell Graham
15 papers · 1 as a fellow
Roxana Dronca
15 papers
AJ
Aminah Jatoi
14 papers

Grants

Genetic Epidemiology of Young-Onset Pancreatic Cancer
National Cancer Institute · K07
Contact PI · $655.5K · Mayo Clinic Rochester
2006–2011

Clinical trials

Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer
Principal investigator · Completed · Phase 2
Mayo Clinic
2020–2025
Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Principal investigator · Unknown · Phase 2
Academic and Community Cancer Research United
2017–2024
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
Principal investigator · Completed · Phase 1
Prism Pharma Co., Ltd.
2013–2015
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Principal investigator · Completed · Phase 1
Mayo Clinic
2008–2012